FindTrial
Sign In

Routine quantitative microbiological screening in ventilated patients with, or at risk of, ALI/ARDS: effects on survival and long-term morbidity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84441248
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-04-24
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory: Acute Respiratory Distress Syndrome (ARDS) + Acute Lung Injury (ALI) Respiratory Acute Respiratory Distress Syndrome (ARDS) + Acute Lung Injury (ALI)

Interventions

1. Identify patients suitable for inclusion into study 2. Seek consultant assent (not one of the investigators) to enter patient into study 3. Randomise to quantitative or non-quantitative culture 4.

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged over 16 years 2. Patient receiving mechanical ventilation 3. Existence of, or risk factors for, ALI/ARDS

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Patient already enrolled in another interventional study 3. Little chance of survival, defined by Simplified Acute Physiologic Score II (SAPS II), over 65 points corresponds to predicted mortality in excess of 77% 4. Contraindication to bronchoscopy at enrolment

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026